• Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Home
  • Events
  • Careers at CAPTIS
  • Log In / Sign In ▼
    • Log In with LinkedIn
    • Register w/out LinkedIn
    • Login w/out LinkedIn
    • Reset Lost Password
  • 🔒 MEMBER AREA ▼
    • View your profile
    • Edit your profile
    • Log out
       ☎ US Offices 1 (800) 445-1839 Toll Free | Europe/Int'l +41 22 518 2100
CAPTIS Executive Search
  • Home
  • You are a Business
    • Executive Search
    • Our Commitments
    • Other Services
    • Our Locations
    • About Us
    • Key Values
  • You are a Healthcare Executive
    • Dealing with CAPTIS
    • Candidate Contact Form
    • Login with LinkedIn
    • Create an Account
    • Log in (Existing Account)
    • WW Trade Shows
      • Medical & Pharmaceutical
      • Orthopedics
      • Spine
      • Cardiovascular
      • Diagnostics
      • Wound Care
      • Plastic & Aesthetic Surgery
      • Surgery
      • Trauma
      • Pediatric Care
    • Industry News
      • News
      • Wall Street Beat
      • Business/Financial News
      • Clinical Trials
      • Musculoskeletal News Roundup
      • Cardiovascular
      • M&A Activity
      • Food & Drug Administration (FDA)
      • Wound Care
      • Practice Management
  • CAPTIS Magazine
    • Healthcare News
    • @CaptisCorp Twitter Timeline
    • Healthcare Events
    • CAPTIS LinkedIn Timeline
    • Articles ➜
      • Recruiting
      • Personal Development
      • News
  • Make an Inquiry
  • Contact Us
    • General Contact Form
    • Healthcare Executive Contact
    • Apply for a position at CAPTIS
    • Call 1 800 445 1839
      (Cell/Mobile US & Canada Toll Free, or Skype)
    • Call +41 22 518 2100
      (Cell/Mobile Swiss Landline Switchboard, or Skype)
  • Search
  • Menu

Captare. Aestimare. Eligere. Succedere.

CAPTIS – Your Global Healthcare & MedTech Executive Search Provider

You are a Business

You are an Executive

Want to work at CAPTIS

Learn about our services

 

 

Executive Search
Submit an inquiry

GET HEADHUNTED!

Create and/or update

your confidential profile

 

Healthcare Executive General Information
Create an account & Add your profile

Go to our Careers page

 

 

 

 

 

CAPTIS Careers

Recent Healthcare News:

01/18/2019/by CAPTIS

ADC Therapeutics announces first patient dosed in Phase I clinical trial of ADCT-601 in advanced solid tumors

ADC Therapeutics, an oncology drug discovery and development…
01/17/2019/by CAPTIS

Acrotech to buy seven hematology/oncology products from Spectrum

01/17/2019/by CAPTIS

Schott to invest €300m in pharmaceutical packaging buisness

01/17/2019/by CAPTIS

Abbott inks deal to test blood donations in Japan

01/17/2019/by CAPTIS

Windgap Medical raises $12m for epinephrine auto-injector

01/17/2019/by CAPTIS

HighLife raises $36m Series B for mitral valve replacement

01/17/2019/by CAPTIS

LivaNova touts studies of its sutureless aortic valve

01/17/2019/by CAPTIS

OtoNexus raises $4.4 million for ear infection detection technology

01/17/2019/by CAPTIS

Johnson & Johnson, Apple ink collab for AFib study

01/17/2019/by CAPTIS

Critical impacts of the government shutdown on the FDA and clinical research

01/17/2019/by CAPTIS

Bioventus launches Osteomatrix+ bone graft

Bioventus announced today that it has started selling Osteomatrix+…
01/17/2019/by CAPTIS

Philips touts new gantry design for Azurion

01/17/2019/by CAPTIS

Itamar Medical to raise $12m with private placement

01/17/2019/by CAPTIS

Focusing on usability can limit medical device recalls: Here’s how

01/17/2019/by CAPTIS

Sandoz launches PFS alternative to epinephrine auto-injector

01/17/2019/by CAPTIS

European scientists develop absorbable bandages

01/17/2019/by CAPTIS

Stimwave touts 6 month MIS SCS trial results

01/17/2019/by CAPTIS

Medtronic kicks off study for pain pump

01/17/2019/by CAPTIS

Cala Health launches trial for Cala Two neurostim device for essential tremor

01/17/2019/by CAPTIS

Proteus debuts digital cancer drug

Go to the Healthcare News

Recent news from your industry: Finance, M&A, Products, Companies and more…

Upcoming Events:

We Suggest:

Becton Dickinson’s fiscal Q1 prelims beat The Street

0 Comments
/
01/17/2019
Becton Dickinson (NYSE:BDX) beat the consensus forecast…
Read more
https://www.captis.com/wp-content/uploads/2019/01/becton-dickinson-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-17 04:18:202019-01-17 05:31:30Becton Dickinson’s fiscal Q1 prelims beat The Street

Janssen gets EC nod for prostate cancer drug Erleada

0 Comments
/
01/17/2019
Erleada is a next generation oral androgen receptor inhibitor…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-17 00:31:502019-01-17 01:31:51Janssen gets EC nod for prostate cancer drug Erleada

Silence’s SLN124 gets orphan designation in Europe for β-Thalassemia

0 Comments
/
01/17/2019
The designation to SLN124 was granted by the Committee for Orphan…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-17 00:31:482019-01-17 01:31:49Silence’s SLN124 gets orphan designation in Europe for β-Thalassemia

Juvenescence closes first tranche of series B financing for further growth and development

0 Comments
/
01/17/2019
Juvenescence intends to complete its $100 million Series B financing…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-17 00:31:462019-01-17 01:31:47Juvenescence closes first tranche of series B financing for further growth and development

Luye Pharma grants AstraZeneca exclusive rights to promote Xuezhikang Capsules in mainland China

0 Comments
/
01/17/2019
This is the first time that a multinational pharmaceutical company…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-17 00:31:442019-01-17 01:31:44Luye Pharma grants AstraZeneca exclusive rights to promote Xuezhikang Capsules in mainland China

Henry Schein pushes back date for animal health spinout

0 Comments
/
01/16/2019
Henry Schein (NSDQ:HSIC) said today that it is shifting…
Read more
https://www.captis.com/wp-content/uploads/2019/01/henry-schein-one-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-16 11:35:422019-01-16 13:01:04Henry Schein pushes back date for animal health spinout

Integer wins $22m in damages from AVX pacer patent spat retrial

0 Comments
/
01/16/2019
Integer Holdings (NYSE:ITGR), formerly known as Greatbatch,…
Read more
https://www.captis.com/wp-content/uploads/2019/01/integer-avx-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-16 10:48:272019-01-16 12:01:30Integer wins $22m in damages from AVX pacer patent spat retrial

Brainsway registers for $30m IPO

0 Comments
/
01/16/2019
Brainsway has registered for an upcoming initial public offering,…
Read more
https://www.captis.com/wp-content/uploads/2019/01/brainsway-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-16 09:38:552019-01-16 11:02:54Brainsway registers for $30m IPO

RFPi wins FDA nod for non-contact blood flow imaging tech

0 Comments
/
01/16/2019
RFPi’s iCertainty shows images of blood flow and perfusion…
Read more
https://www.captis.com/wp-content/uploads/2019/01/RFPibloodflowimage-300x195.jpg 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-16 08:45:082019-01-16 10:01:29RFPi wins FDA nod for non-contact blood flow imaging tech

JustRight Surgical rebrands to Bolder Surgical, raises $27m

0 Comments
/
01/16/2019
Bolder Surgical, formerly known as JustRight Surgical, said…
Read more
https://www.captis.com/wp-content/uploads/2019/01/bolder-surgical-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-16 08:44:012019-01-16 10:01:27JustRight Surgical rebrands to Bolder Surgical, raises $27m

Zoll Medical wins $400m DoD patient monitoring supply contract

0 Comments
/
01/16/2019
Zoll Medical has won a $400 million contract with the U.S.…
Read more
https://www.captis.com/wp-content/uploads/2019/01/zoll-medical-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-16 07:47:412019-01-16 09:01:38Zoll Medical wins $400m DoD patient monitoring supply contract

QT Vascular expands pivotal trial of Chocolate Touch DCB

0 Comments
/
01/16/2019
QT Vascular said today that the FDA approved the company’s…
Read more
https://www.captis.com/wp-content/uploads/2019/01/qt-vascular-updated-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-16 07:28:462019-01-16 08:31:18QT Vascular expands pivotal trial of Chocolate Touch DCB

Kyocera buys part of Renovis Surgical

0 Comments
/
01/16/2019
Kyoto, Japan-based Kyocera (TYO:6971) said it will…
Read more
https://www.captis.com/wp-content/uploads/2019/01/KyoceraRenovis-300x195.jpg 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-16 07:16:442019-01-16 08:31:16Kyocera buys part of Renovis Surgical

Gottlieb calls 400 workers back from furlough for ‘key inspections’

0 Comments
/
01/16/2019
Approximately 400 employees at the FDA are being called back…
Read more
https://www.captis.com/wp-content/uploads/2019/01/fda-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-16 06:45:192019-01-16 08:01:34Gottlieb calls 400 workers back from furlough for ‘key inspections’

Abbott to acquire mitral valve device maker Cephea Valve Tech

0 Comments
/
01/16/2019
Abbott (NYSE:ABT) said today that it plans to acquire mitral…
Read more
https://www.captis.com/wp-content/uploads/2019/01/abbott-150x97-1.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-16 06:02:542019-01-16 07:32:26Abbott to acquire mitral valve device maker Cephea Valve Tech

Rep. Cummings talks drug pricing with HHS chief

0 Comments
/
01/16/2019
Days after unveiling an investigation into the drug…
Read more
https://www.captis.com/wp-content/uploads/2019/01/generic-pills-money-7x4-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-16 04:57:032019-01-16 06:02:02Rep. Cummings talks drug pricing with HHS chief

Sanofi to use Biomunex’s BiXAb platform to generate antibody therapeutics

0 Comments
/
01/16/2019
As part of the deal, Sanofi will use the BiXAb platform of Biomunex…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-16 00:31:162019-01-16 01:31:16Sanofi to use Biomunex’s BiXAb platform to generate antibody therapeutics

Bioharmony Therapeutics, Boehringer Ingelheim to advance bacteriophage lysin therapeutics to treat f multi-drug resistant bacterial infection

0 Comments
/
01/16/2019
Bioharmony licensed this technology from the Rockefeller University.…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-16 00:01:052019-01-16 01:01:07Bioharmony Therapeutics, Boehringer Ingelheim to advance bacteriophage lysin therapeutics to treat f multi-drug resistant bacterial infection

Exelixis announces U.S. FDA approval of CABOMETYX (cabozantinib) tablets for previously treated hepatocellular carcinoma

0 Comments
/
01/15/2019
HCC is the most common form of liver cancer and the fastest-rising…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-15 23:31:242019-01-16 00:31:25Exelixis announces U.S. FDA approval of CABOMETYX (cabozantinib) tablets for previously treated hepatocellular carcinoma

MobileODT touts colposcope-based cervical cancer detection AI

0 Comments
/
01/15/2019
MobileODT said last week that it is implementing a new…
Read more
https://www.captis.com/wp-content/uploads/2019/01/mobileodt-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-01-15 12:04:452019-01-15 13:31:18MobileODT touts colposcope-based cervical cancer detection AI
PreviousNext

  • Thorough Network

  • Deep Knowledge

  • Comprehensive Process

  • Ethical Approach

  • Confidentiality

  • Assessment Capacity

99%

Percentage of successful project completion

85%

Of placed executives remain with the client company 3 or more years

  • Share on Facebook
  • Share on Twitter
  • Share on Google+
  • Share on Pinterest
  • Share on Linkedin
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail

News from Twitter

Twitter
Novartis Cancer
Novartis Cancer
@NovartisCancer

Cancer is not a ‘one size fits all,’ nor is the way we treat it. We are working to better understand the different ways a cancer can mutate so we can discover new approaches to treat some of the most difficult-to-treat types of the disease. #ReimagineMedicine #ESMO18 pic.twitter.com/41QL…

reply retweet favorite
6:56 pm · 10/24/2018 ·
Retweeted by CAPTIS
Twitter
Epic CV
Epic CV
@Epic_CV

Read carefully employer's directions on how to apply. #resume #resumetips

reply retweet favorite
7:47 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
World Spine Care
World Spine Care
@WorldSpineCare

Here are 5 Tips to Avoid Back Pain from #WorldSpineDay. #Exercise #Posture #Stress #HealthyEating #Strength pic.twitter.com/AT1D…

reply retweet favorite
7:46 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Neurochecklists
Neurochecklists
@neurochecklists

Large-vessel giant cell arteritis: diagnosis, monitoring and management | Rheumatology | Oxford Academic academic.oup.com/rhe…

reply retweet favorite
7:40 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Stryker Endoscopy
Stryker Endoscopy
@StrykerEndo

Scientists have made an unexpected discovery while investigating the triggering factors of #ColonCancer: Cell stress in combination with an altered microbiota in the colon drives tumor growth. Learn more: ow.ly/JxtK30meLTY pic.twitter.com/U51Q…

reply retweet favorite
7:39 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Implantech
Implantech
@Implantech

If you are in Dallas attending the AAFPRS 12th International Symposium of Facial Plastic Surgery don’t miss out on this Breakfast Symposium tomorrow morning with Dr. William Binder that is sponsored by Implantech! #implantech #superiorpatientaesthetics #implantechrewards #aafprs pic.twitter.com/HCzK…

reply retweet favorite
7:38 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
American College of Cardiology
American College of Cardiology
@ACCinTouch

Less than one month left to submit your science for #ACC19! Abstract & case submissions are due Oct. 16. Learn more: ow.ly/4nyf30lYZxh pic.twitter.com/Mnwv…

reply retweet favorite
4:46 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Novartis Cancer
Novartis Cancer
@NovartisCancer

With #CARTcell therapy, an inactive virus programs T cells with new genetic information to help recognize specific antigens found on normal cells and certain blood cancer cells. As the CAR-T cells multiply, new copies also gain this ability. #CARTCellStory pic.twitter.com/Xuoh…

reply retweet favorite
4:42 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Integra LifeSciences
Integra LifeSciences
@integra_life

Make plans to visit the Integra LifeSciences Booth# 919 during Plastic Surgery The Meeting September 28th - October 1st. #Integra_LifeSciences #DurableIsBeautiful #PSTM18 #ASPS #PlasticSurgery pic.twitter.com/8QGv…

reply retweet favorite
4:42 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Fundamental Surgery
Fundamental Surgery
@FundamentalSurg

We are live at #NASS2018 stand 2649. Get hands-on with the world's leading surgical #simulator in #VR with #haptics and experience the future of surgical training. #wearefundamental fundamentalsurgery.c… pic.twitter.com/NgzA…

reply retweet favorite
4:41 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
TRX Orthopedics
TRX Orthopedics
@TRXOrtho

Great things happening at Tissue Regenix! Plan to visit our booth at the AAOS meeting in New Orleans, under the CellRight Technologies banner #5413. @AAOS1

reply retweet favorite
8:34 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Corin Group
Corin Group
@corintechnology

All evaluation cases for the new Corin Dual Mobility option for the Trinity Acetabular cup system have now been completed and we're looking forward to the full launch. Click lnkd.in/g8ariEY for details #orthopaedics #technology #totalhip #uniquehip pic.twitter.com/SPsy…

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Omar Ishrak
Omar Ishrak
@MedtronicCEO

Thank you to our @Medtronic employees around the globe! Q3 saw strong, balanced results, with diversified performance in all groups and regions. #MDTEarnings

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Cardiovascular News
Cardiovascular News
@Cardiovasc_bio

#cardiovascular news CorFlow Presents Fundamental New Insights into the Coronary Microcirculation at ACC - CorFlow Therapeutics AG corflowtherapeutics.… today announced that the company will present fundamental new insights into the coronary microci... ow.ly/OlaG50gAElO

reply retweet favorite
8:32 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Integra LifeSciences
Integra LifeSciences
@integra_life

Welcome Sravan Emany, our new vice president, treasurer and head of investor relations. investor.integralife… pic.twitter.com/wzt5…

reply retweet favorite
8:31 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
José Luis Maçãs
José Luis Maçãs
@zeluismacas

Read in this edition all about Novartis Oncology’s ground-breaking CAR-T therapy; how SwissMedic is leading the world in terms of regulatory innovation; the story of Actelion’s acquisition by J&J and the subsequent emergence of a new entity – Idorsia. pharmaboardroom.com/…

reply retweet favorite
11:29 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
SOFCOT
SOFCOT
@sofcot_ortho

Thème du congrès SOFCOT 2018 : "La Décision Médicale" pic.twitter.com/hJT5…

reply retweet favorite
11:25 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
EUROSPINE
EUROSPINE
@EUROSPINESoc

Exactly 3 weeks left to submit your abstract for #EUROSPINE2018 - #deadline 1 March 2018 #research #spine #SpineResearch #spineSurgery #SpinalDisorder #ScientificPaper #BasicScience #ClinicalResearch #PublishResearch @EurSpineJournal buff.ly/2ExMQ7e pic.twitter.com/Fx2Q…

reply retweet favorite
11:25 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
Olea Medical
Olea Medical
@OleaMedical

Throughout the week, we are in #Bruges alongside Prof. Jan Casselman for an #Erasmus course program on #ENT imaging, held at the Oud Sint-Jan congress centre. The training of around 170 radiologists is based on images from our post-processing solution Olea Sphere®V3.0. #MRI pic.twitter.com/KSUU…

reply retweet favorite
11:24 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
Olea Medical
Olea Medical
@OleaMedical

#ArtificialIntelligence is currently in the center of all discussions, medical #imaging including. What will be impacted, notably in #MSK imaging? Listen to the answer of Pr Cotten from Lille’s CHRU : youtu.be/93nLXGX4hEk

reply retweet favorite
5:20 pm · 01/24/2018 ·
Retweeted by CAPTIS
Follow @CaptisCorp

Follow CAPTIS



CAPTIS
Followon TwitterSubscribeto RSS Feed

We Recommend

Our very best and up-to-date selection of healthcare Industries' News (Products, Markets, Companies, R&D, Technology, Opportunities, Investment & Finance...).
Read at Healthcare News

CAPTIS Newsletter

Call CAPTIS

United States Offices
1 (800) 445-1839

(United States & Canada Toll Free)

Europe & International
+41 22 518 2100

© CAPTIS - Executive Search - 2017 - copyright@captis.com
  • Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Events
  • For Healthcare Executives
  • Legal & Privacy Notes, GDPR & Cookies Policy
  • Client Area
X
Thank you for visiting our new website! Help us improve, let us know your feedback (Anonymous 2 min survey)
Survey
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OK, got itCookies Policy
Scroll to top